Human chorionic gonadotrophin (HCG) may substitute FSH to complete follicular growth in
IVF cycles. This may be useful in the prevention of ovarian hyperstimulation syndrome …

Extending the FSH window for multifollicular development by administering FSH from the
midfollicular phase onward constitutes a novel mild protocol for ovarian stimulation for in …

OBJECTIVE: To highlight the clinical role of standard GH replacement treatment on fertility
and pregnancy outcomes in four infertile eugonadal women with GH deficiency (GHD) …

We examined whether treatment with minimum‐dose stimulation (MS) protocol enhances
clinical pregnancy rates compared to high‐dose stimulation (HS) protocol. A retrospective …

OBJECTIVE: The lowest effective hCG dose in high responders during IVF–embryo transfer
(ET) has not been established. This study was performed to confirm that a dose of 3,300 IU …

The results of several studies about the effectiveness of recombinant luteinizing hormone
(rLH) supplementation in poor responder in vitro fertilization (IVF) patients were conflicting …

OBJECTIVE: To compare the efficacy of flare-up and GnRH-antagonist treatment in poor-
responder patients. DESIGN: Randomized prospective study. SETTING: Assisted …

Background Recently, a novel approach with delaying the start of controlled ovarian
stimulation along with gonadotropin-releasing hormone (GnRH) antagonist pretreatment for …

Objective: To determine whether a controlled ovarian hyperstimulation (COH) regimen that
involves GnRH agonist (GnRH-a) discontinuation before administration of gonadotropins …

This study aims to compare the efficacy of recombinant LH (rLH) supplementation for
ovarian stimulation in gonadotrophin-releasing hormone-antagonist protocol for …